| 0 (0%) | 04-25 18:18 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 12.92 | 1-year : | 15.1 |
| Resists | First : | 11.06 | Second : | 12.92 |
| Pivot price | 11.01 |
|||
| Supports | First : | 11.02 | Second : | 10.98 |
| MAs | MA(5) : | 11.05 |
MA(20) : | 11 |
| MA(100) : | 11.03 |
MA(250) : | 10.92 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 100 | D(3) : | 88.8 |
| RSI | RSI(14): 83.9 | |||
| 52-week | High : | 11.94 | Low : | 10.65 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ PPHP ] has closed below upper band by 8.5%. Bollinger Bands are 10% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 11.1 - 11.15 | 11.15 - 11.19 |
| Low: | 10.92 - 10.99 | 10.99 - 11.05 |
| Close: | 10.96 - 11.08 | 11.08 - 11.17 |
Fri, 05 Jan 2018
Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract ... - GlobeNewswire
Fri, 07 Jul 2017
Peregrine Pharmaceuticals Announces Reverse Stock Split - GlobeNewswire
Tue, 10 Jun 2014
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock - Yahoo Movies UK
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 1 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 82.2 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 1 (K) |
| EPS | -0.38 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -2.8 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -4.5 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -1 (M) |
| Levered Free Cash Flow | 49 (M) |
| PE Ratio | -29.14 |
| PEG Ratio | 0 |
| Price to Book value | -3.96 |
| Price to Sales | 0 |
| Price to Cash Flow | -10.8 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|